Navigation Links
Palatin Technologies Reports Positive Results for Phase 2B Bremelanotide Female Sexual Dysfunction Trial
Date:11/8/2012

CRANBURY, N.J., Nov. 8, 2012 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) today reported positive top-line results, including the successful achievement of statistical significance for the primary endpoint and key secondary endpoints in its Phase 2B clinical trial evaluating the efficacy and safety of bremelanotide for the treatment of female sexual dysfunction (FSD).

The data demonstrate that women taking bremelanotide showed statistically significant increases in the number of Satisfying Sexual Events (SSEs) and also showed statistically significant improved measures of overall sexual functioning and distress related to sexual dysfunction, compared with placebo.

The primary endpoint data analysis of 327 pre-menopausal women with female sexual arousal disorder (FSAD), hypoactive sexual desire disorder (HSDD), or a combination of both disorders, the most common types of FSD, shows a clinically meaningful and statistically significant improvement (p=0.018) in the number of SSEs in women taking bremelanotide doses (mean change from 1.6 at baseline increasing to 2.4; pooled 1.25 mg and 1.75 mg doses) versus placebo (mean change from 1.7 at baseline increasing to 1.9) over the study period, resulting in a 50% increase in SSEs with bremelanotide versus 12% with placebo.

"We are extremely pleased to report the successful completion of this trial, which achieved statistical significance in our primary endpoint and key secondary endpoints using independently developed and validated measurement tools. Importantly, we met the objectives of the trial which demonstrated excellent safety and efficacy of the drug and identified doses for advancement into Phase 3 trials and activities" stated Carl Spana, Ph.D., President and CEO of Palatin. "Our next steps are to continue to compile and analyze additional data, to start the preparation process for an end-of-Phase 2 meeting with the FDA, and to further our discussions with potential colla
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
3. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
4. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
5. Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
6. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
7. Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
8. Palatin Technologies, Inc. Announces Pricing of $35 Million Private Placement of Common Stock and Warrants
9. Palatin Technologies, Inc. To Report Fiscal Year 2012 Fourth Quarter Results; Teleconference and Webcast to be held on September 11, 2012
10. Palatin Technologies Provides Update Regarding Its Obesity Research/Development Collaboration with AstraZeneca
11. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... July 18, 2014 Emerging Nuclear Power ... to 2030 , Summary , The latest report from ... Companies and Development Analysis to 2030 covers the emerging ... also provides comprehensive information on key market players and ... reactors in various countries across the world has also ...
(Date:7/18/2014)... BASEL, Switzerland , July 18, 2014 ... for Education in Animal Research for the third consecutive ... Moscow State University, will attend a 1-week course at ... rules of the 3Rs (Replace, Reduce, Refine). As head ... University, Popov has been given the task of adapting ...
(Date:7/17/2014)... MOUNTAIN VIEW, Calif. , July 17, ... in translational preclinical research, today announced the addition of ... expert veterinary interventionalist, and Benigno Mills , a ... Team. In addition, to better serve our clients, we ... media accounts on Twitter , Facebook ...
(Date:7/17/2014)... devices can only work with a certain incident polarization ... shift the polarization direction of linearly polarized light. A ... out of a birefringent material (such as quartz or ... the thickness of the crystal, the wavelength of light. ... difficulty to integrate on circuits. Then what kind of ...
Breaking Biology Technology:Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 3Young Moscovite Researcher Receives this Year's "Basel Declaration Award for Education in Animal Research" 2SURPASS Announces Two Strategic Hires in Silicon Valley Facility and Launch of Social Media Accounts 2SURPASS Announces Two Strategic Hires in Silicon Valley Facility and Launch of Social Media Accounts 3
... July 7, 2011 , Amsterdam Molecular ... gene therapy, announced today that it has filed,a request ... with the European Medicines Agency.,Glybera is a gene ... expects that the re-examination of,the dossier will be completed ...
... modeling and advanced materials analysis techniques at synchrotron ... at Buffalo (UB) and including the National Institute ... at Lawrence Berkeley National Laboratory and SEMATECH* has ... seriously degrade the otherwise near-magical electronic properties of ...
... July 7, 2011 For the first time since ... have isolated a human blood stem cell in its ... of regenerating the entire blood system. This breakthrough opens ... cells to treat cancer and other debilitating diseases more ...
Cached Biology Technology:Amsterdam Molecular Therapeutics Files Glybera® European Marketing Application for Re-examination 2Graphene: What can go wrong? new studies point to wrinkles, process contaminants 2"Pure" Human Blood Stem-Cell Discovery Opens Door to Expanding Cells for More Clinical Use 2"Pure" Human Blood Stem-Cell Discovery Opens Door to Expanding Cells for More Clinical Use 3
(Date:7/21/2014)... high-fat foods cause you to lose your sense of ... neuroscientists says so, and it has researchers taking a ... whole range of human functions that were not traditionally ... opens up a lot of possibilities for obesity research," ... led the study examining how high-fat foods impacted smell. ...
(Date:7/21/2014)... Growers of annual bedding plant seedlings or plugs ... a large stem diameter and high root dry ... during shipping and transplant. To achieve these desirable ... on supplemental lighting from high-pressure sodium lamps during ... diodes (LEDs) can give greenhouse growers other lighting ...
(Date:7/21/2014)... animals cannot regulate their body temperature, so their cells ... at slightly colder temperatures, some biological processes in the ... throw the cells, delicate chemical balance out of whack. ... coordinated. Now researchers from the University of Rochester and ... they do that. , "The production of proteins ...
Breaking Biology News(10 mins):New research links bad diet to loss of smell 2LEDs shine in bedding plant production study 2When temperatures get cold, newly-discovered process helps fruit flies cope 2
... frequently causes gastric ulcers and is also one of the ... infection is also associated with another gastric cancer risk factor, ... Clinical Investigation , researchers led by Richard Peek at Vanderbilt ... -induced gastric cancer. Peek and colleagues found that low iron ...
... in German . The climate after ... was cool, later very warm and then cool again. Thanks ... as paleontologists from the University of Zurich have reconstructed. The ... atmosphere, initially gave rise to new, short-lived species. In the ...
... This press release is available in German . ... produce energy from waste in biogas plants. Researchers from Bielefeld ... to find out which microbes do the best job. They ... in selected biogas plants up and down Germany. From the ...
Cached Biology News:Ironing out the link between H. pylori infection and gastric cancer 2Ups and downs of biodiversity after mass extinction 2A giant puzzle with billions of pieces 2A giant puzzle with billions of pieces 3